@article{ijcd2021917,
author={Freeman, Hugh J.},
title={The COVID-19 Vaccination Debate: COVID-19 and Celiac Disease},
journal={International Journal of Celiac Disease},
volume={9},
number={1},
pages={3--5},
year={2021},
url={http://pubs.sciepub.com/ijcd/9/1/7},
issn={2334-3486},
abstract={COVID-19 is a novel coronavirus that appears to cause a systemic disorder largely marked by fever and respiratory symptoms as well as diarrhea. The agent gains access to respiratory and gastrointestinal cells through a complex molecular mechanism associated with increased ACE2 receptor expression on brush border membranes of epithelial cells. Because some autoimmune-based disorders, including celiac disease, appear to be at increased risk for viral and community-acquired bacterial infections, a number of preliminary survey studies from different countries, largely web-based or telephone-based, have suggested that COVID-19 infection risk is not increased in celiac disease. However, specific sub-groups of patients with celiac disease have not been thoroughly evaluated. For example, selective immunoglobulin A deficiency or other immune deficiency states with celiac disease may represent a special risk group for COVID-19 and other viral infectious agents.},
doi={10.12691/ijcd-9-1-7}
publisher={Science and Education Publishing}
}